PH2113 - COPD Flashcards

1
Q

What is the difference between asthma and COPD?

A

Asthma is episodic
COPD is chronic

the type of inflammation is different to asthma and this has an impact on the disease progression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the symptoms of COPD?

A
Increasing breathlessness
Persistent chesty cough
Frequent chest infections
- loss of cilia responsible for clearing mucus
Persistent wheezing
- airway narrowing
- oedema
- swelling of wall
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the third largest cause of death from respiratory disease?

A

Pneumonia (43%)
Respiratory cancer (23%)
COPD (20%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How has the incidence of COPD changed over the last 10 years?

A

Incidence of COPD has risen approximately 30% over the last 10 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

describe the symptoms of COPD and asthma

A
COPD
Increasing breathlessness
Persistent chesty cough
Frequent chest infections
Persistent wheezing
Symptoms will get progressively worse
No hereditary link
Presentation older patients
Periods where symptoms get much worse (exacerbations)
Airway hyper-responsiveness present

Asthma
Episodic breathlessness
Cough associated with asthma episodes
Less increased frequency of chest infections
Episodes of wheezing
Untreated, frequency and severity of symptoms can get worse
Some hereditary links
Presentation at any age
Periods where symptoms get much worse (exacerbations)
Airway hyper-responsiveness present

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What proportion of COPD patients are smokers?

A

~ 90%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What proportion of smokers develop COPD?

A

15%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the pathology of COPD?

A

Non-reversible air flow obstruction
Dominant inflammatory cell in the lungs in the neutrophil
- in asthma it is the eosinophil
No thickening of the basement membrane, hypertrophy, hyperplasia or airway smooth muscle
Mucus hypersecretion
- can contribute to airway narrowing
Bronchoconstriction
- high parasympathetic tone
Airway hyper-responsiveness
- similar to asthma
Epithelial shedding and damage to cilia (mucus build up)
- similar to asthma
Oedema
- increased access of white blood cells to lung tissue
Damage to the alveolar extracellular matrix leading to irreversible loss of lung elasticity and enlargement of the respiratory air space
- emphysema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the key inflammatory cell in COPD?

A

Neutrophil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What causes COPD?

A

Cigarette smoke and other irritants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

compare the pathology of asthma and COPD

A

Firstly, the structural changes in the lung is irreversible and there are no pharmacological treatments that can prevent its progression. This is not the case in asthma, were corticosteroids can effectively slow or stop the pathological changes in lung architecture.

Unlike asthma where the predominant inflammatory cell found in the lungs of asthma patients is the eosinophil, for COPD patients it is the neutrophil. There is often some overlap between severe asthma and COPD. Some unfortunate patients have both asthma and COPD at the same time. Severe asthma, as discussed in the optional lesson 5, is associated with a larger population of neutrophils. The neutrophil may partly explain why the inflammation associated with COPD and some types of asthma is less sensitive to treatment with corticosteroids. This is due to the type of corticosteroid receptor found in neutrophils compared to that expressed in eosinophils. View optional lesson 5 for more details.

Distinct from asthma, there is no thickening of smooth muscle in the bronchiole wall. This does not mean the COPD patients are not associated with hyper-responsiveness which is indeed one of the features of COPD. However, thickening of smooth muscle does not play a role in the lungs of COPD patients.

As in some types of asthma, pulmonary inflammation associated with COPD causes a hypersecretion of mucous. This can contribute to the airway obstruction that contributes to the dyspnoea experienced by COPD patients.

Asthma attacks are triggered by exposure to allergens where the response involves IgE. This is not the case in COPD. The best analogy is to consider COPD as an exaggerated irritant response that leads to an inflammatory response.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the only intervention which limits COPD progression?

A

Stopping smoking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the non-pharmacological management strategies of stable COPD?

A
  1. Smoking cessation
    - only proven method to improve life expectancy
  2. Pulmonary rehabilitation
  3. Long-term oxygen therapy
  4. Surgery

Strategies 2, 3 and 4 are palliative (relieving pain without dealing with the cause of the condition)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe smoking cessation as an intervention for COPD

A
The most important/effective intervention
Slows disease progression
DOES NOT RESTORE LOST FUNCTION
Sudden cessation better than gradual
Big role for pharmacists!
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Which COPD intervention can be used in patients who are functionally disabled?

A

Pulmonary rehabilitation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What does pulmonary rehabilitation involve?

A
  • disease education
  • exercise
  • dietary advice
  • psychological care
17
Q

Which COPD intervention can be used in patients with severe impairment of airflow?
- FEV1 < 30% of normal

A

Long-term oxygen therapy

18
Q

What are the risks of long term oxygen therapy?

A
Can cause respiratory depression
Need to measure oxygen saturation levels
- pulse oximeter
Therapy for at least 15 hours/day
- 20 hours/day is better
Smoking and oxygen therapy is a bad combination
19
Q

What causes alveolae to collapse into each other forming large sacs?

A

Emphysema

20
Q

What is a bullectomy?

A

Removal of a bullae

  • a bullae is a pocket of air formed from the destruction of individual alveoli in emphysema
  • removal of the bullae removes dead air pockets and reduces a hyper inflated lung volume that might prevent proper diaphragm function
21
Q

What is the treatment for end-stage COPD?

A

Lung transplant

- one or both lungs

22
Q

Why is lung transplantation tricky in end-stage COPD patients?

A

Patients need to be fit enough for surgery but COPD needs to be sufficiently advanced to qualify

23
Q

What are the first inhaler treatments offered for COPD and when would you offer them ?

A

Fundamentals of COPD care:
• Offer treatment and support to stop smoking
• Offer pneumococcal and influenza vaccinations
• Offer pulmonary rehabilitation if indicated
• Co-develop a personalised self-management plan
• Optimise treatment for comorbidities

all the above interventions have been offered
(if appropriate), and
• inhaled therapies are needed to relieve breathlessness
and exercise limitation, and
• people have been trained to use inhalers and can
demonstrate satisfactory technique

Offer SABA or SAMA to use as needed

24
Q

What are the symptoms of COPD exacerbation?

A

Worsening breathlessness
Cough
Increased sputum production
Change in sputum colour

25
Q

Which medications can be used to manage COPD symptoms?

A
  • antibiotics
  • oral corticosteroids
  • oxygen therapy
  • physiotherapy
  • hospital therapy
26
Q

When can antibiotics be used to treat exacerbations of COPD?

A

When a bacterial infection is causing worsening symptoms

27
Q

Why are oral corticosteroids contraindicated for use in acute exacerbations of COPD?

A

Potential risk of pneumonia

28
Q

When can oral corticosteroids be used in the management of acute exacerbations of COPD?

A

Can be used prophylactically to reduce frequency of exacerbations
- early intervention necessary for optimal efficacy

29
Q

What is the aim of oxygen therapy in the acute exacerbations of COPD?

A

To combat hypoxia

- titrate to keep O2 saturation within target limits

30
Q

What is the aim of physiotherapy in acute exacerbations of COPD?

A

Helps sputum clearance

31
Q

What therapies can be delivered in hospital in acute exacerbations of COPD?

A

IV theophylline
Invasive ventilation
Non-invasive ventillation + doxapram

32
Q

What is a restrictive airway disease?

A

A lung condition where the amount of air that can be inhaled is reduced as the lung becomes less stretchy

33
Q

What is an obstructive airway disease?

A

A lung condition where the air flow moving in and out of the lungs is reduced